Approaches to Pharmaceutical Analysis of an Innovative Liposomal Preparation for Treating Hepatitis C


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The composite Y14/siUTR, a complex consisting of cationic lipopeptide Y14 as an excipient and pharmaceutical substance of small interfering RNAtargeted against the UTR region of hepatitis C virus (siUTR), was investigated. The composite was intended to inhibit the hepatitis C virus replication cycle. The present work was aimed at developing pharmaceutical analytical methods for the components of this composite using HPLC-UV and UV spectroscopy.

About the authors

V. V. Smirnov

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation; Institute of Immunology, Federal Medico-Biological Agency of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: chem@folium.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051; Moscow, 115478; Moscow, 119991

L. M. Krasnykh

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051

I. P. Shilovskii

Institute of Immunology, Federal Medico-Biological Agency of the Russian Federation

Email: chem@folium.ru
Russian Federation, Moscow, 115478

A. P. Ryzhenkova

I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: chem@folium.ru
Russian Federation, Moscow, 119991

M. R. Khaitov

Institute of Immunology, Federal Medico-Biological Agency of the Russian Federation

Email: chem@folium.ru
Russian Federation, Moscow, 115478

V. N. Drozdov

I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: chem@folium.ru
Russian Federation, Moscow, 119991


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies